You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. FDA approves darolutamide for metastatic castration-sensitive prostate cancer
- 2. ESPN's Jay Harris Diagnosed With Prostate Cancer
- 3. It's my goal to live to 100 – and it's not just diet and exercise that will help me achieve it
- 4. Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms
- 5. Why is there such a generational divide in views on sex and gender in Britain? | Susanna Rustin
- 6. Private Astronaut Mission Includes Research to Open Space to Astronauts With Diabetes and Enable Early Cancer Detection
- 7. Efficacy and safety of Eribulin-based chemotherapy in HER2 negative advanced breast cancer patients: a real-world study
- 8. Prediction of metastatic risk of renal clear cell carcinoma based on CT radiomics analysis
- 9. Case Report: Liver and bladder metastasis in a patient with HR-positive, HER2-low breast cancer
- 10. Avenzo begins Phase I/II trial of CDK4 selective inhibitor for breast cancer
Last updated at 11:40 GMT
Hot News Makers
Health/Pharma Companies
-
189743.41
-
141143.46
-
48290.38
-
8247.04
-
8031.93
-
6051.91
-
4300.47
-
4258.75
-
3824.66
-
3086.57
Drugs, Treatments, Trials
-
14828.59
-
12141.06
-
11588.67
-
7852.34
-
4424.79
-
4266.76
-
3883.43
-
3821.67
-
3582.82
-
3527.67
Last updated at 11:10 GMT
